[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivani Medical Inc (VANI)

Vivani Medical Inc (VANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 99,170
  • Shares Outstanding, K 86,235
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,610 K
  • EBIT $ -28 M
  • EBITDA $ -27 M
  • 60-Month Beta 2.31
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.20

Options Overview Details

View History
  • Implied Volatility 308.24% (+2.61%)
  • Historical Volatility 44.42%
  • IV Percentile 67%
  • IV Rank 35.64%
  • IV High 692.63% on 12/11/25
  • IV Low 95.36% on 08/13/25
  • Expected Move (DTE 28) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 56
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 2,508
  • Open Int (30-Day) 2,393
  • Expected Range 1.1500 to 1.1500

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.08
  • Number of Estimates 1
  • High Estimate $-0.08
  • Low Estimate $-0.08
  • Prior Year $-0.12
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1000 +4.55%
on 06/15/26
1.3300 -13.53%
on 06/01/26
+0.0100 (+0.88%)
since 05/18/26
3-Month
0.9228 +24.62%
on 03/30/26
1.5300 -24.84%
on 04/20/26
-0.0200 (-1.71%)
since 03/18/26
52-Week
0.9228 +24.62%
on 03/30/26
1.9200 -40.10%
on 10/21/25
unch (unch)
since 06/18/25

Most Recent Stories

More News
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026

ALAMEDA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. ( NASDAQ: VANI ) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra...

VANI : 1.1500 (unch)
Vivani Medical: Q1 Earnings Snapshot

Vivani Medical: Q1 Earnings Snapshot

VANI : 1.1500 (unch)
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026 $28 million in cash, cash equivalents,...

VANI : 1.1500 (unch)
Vivani Medical: Q4 Earnings Snapshot

Vivani Medical: Q4 Earnings Snapshot

VANI : 1.1500 (unch)
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra long-acting semaglutide implant under...

VANI : 1.1500 (unch)
Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology  Cortigent is the only company to have obtained FDA approval of a device providing artificial...

VANI : 1.1500 (unch)
Vivani Medical, Inc. Announces Closing of Common Stock Offering

ALAMEDA, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

VANI : 1.1500 (unch)
Vivani Medical, Inc. Announces Pricing of Common Stock Offering

ALAMEDA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...

VANI : 1.1500 (unch)
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026

Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology  The company’s new Orion cortical stimulation system for visual perception, designed to...

VANI : 1.1500 (unch)
Vivani Medical: Q3 Earnings Snapshot

Vivani Medical: Q3 Earnings Snapshot

VANI : 1.1500 (unch)

Business Summary

Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second...

See More

Key Turning Points

3rd Resistance Point 1.1982
2nd Resistance Point 1.1885
1st Resistance Point 1.1693
Last Price 1.1500
1st Support Level 1.1404
2nd Support Level 1.1307
3rd Support Level 1.1115

See More

52-Week High 1.9200
Fibonacci 61.8% 1.5391
Fibonacci 50% 1.4214
Fibonacci 38.2% 1.3037
Last Price 1.1500
52-Week Low 0.9228

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.